Details of the Drug

General Information of Drug (ID: DMVT96Q)

Drug Name
BBP-711
Indication
Disease Entry ICD 11 Status REF
Primary hyperoxaluria type 1 5C51.20 Phase 1 [1]
Drug Type
Small molecule
Cross-matching ID
TTD ID
D1R9KZ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
2-Hydroxyacid oxidase 1 (HAO1) TT0A11O HAOX1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04876924) A Phase 1, Randomized, Double-Blinded, Placebo-controlled, Single and Multiple-Ascending Dose Study of the Safety, Tolerability, Food Effect, Pharmacokinetics, and Pharmacodynamics of BBP-711 (ORF-229) in Healthy Adult Subjects. U.S.National Institutes of Health.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight